The plant sterol diosgenin has been shown to stimulate biliary cholesterol secretion in mice without affecting the expression of the adenosine triphosphate-binding cassette transporter heterodimer Abcg5/g8. The aim of this study was to investigate the mechanism of diosgenininduced cholesterol hypersecretion and to identify the genes involved. Surprisingly, despite its lack of effect on Abcg5/g8 expression in wild-type mice, diosgenin did not stimulate biliary cholesterol secretion in mice deficient for Abcg8. Analysis of the kinetics of cholesterol secretion suggested that diosgenin probably activates a step before Abcg5/g8. To identify potential diosgenin targets, gene expression profiling was performed in mice fed a diosgeninsupplemented diet. Diosgenin feeding increased hepatic expression of genes involved in cholesterol synthesis as well as genes encoding for several cytochrome P450s. No significant change in expression of known cholesterol transporters was found. Comparison with published expression-profiling data for Srebp2-overexpressing mice, another mouse model in which biliary cholesterol secretion is elevated, revealed a number of genes with unknown function that were upregulated in both diosgenin-fed mice and mice overexpressing Srebp2.In conclusion, we found that although Abcg8 is essential for most diosgenin-induced biliary cholesterol hypersecretion, diosgenin probably does not interact directly with Abcg5/Abcg8, but rather increases cholesterol delivery to the heterodimer. T he human liver secretes approximately 1 g of cholesterol per day into the bile. Most of this cholesterol is taken up from the blood in the form of lipoproteins. The pathways involved in transhepatic cholesterol trafficking into bile are still largely unknown. A number of intracellular proteins such as Niemann Pick C 1 and 2, sterol carrier protein 2, liver-type fatty acid binding protein, Rab9, and caveolins have been implicated, but their quantitative importance is unknown (see for review Soccio and Breslow 1 and Ory 2 ). After arrival at the canalicular membrane of the hepatocyte, cholesterol is secreted into the bile. It has long been assumed that biliary cholesterol secretion was not protein mediated. This concept changed with the discovery of the adenosine triphosphate-binding cassette half transporters ABCG5 and ABGG8. Patients with mutations in either of these genes show increased intestinal absorption of sterols as well as decreased biliary sterol secretion, suggesting a primary role of these transporters in plant sterol metabolism as well as in cholesterol transport. [3][4][5] The important role of Abcg5/g8 in biliary cholesterol output was confirmed in mice overexpressing human ABCG5/G8 or in mice lacking both genes, indicating that most biliary cholesterol secretion is mediated by Abcg5/g8. 6,7 However, it should be noted that 10% to 30% of biliary cholesterol secretion is independent of Abcg5/g8 activity. [7][8][9] We recently showed in a variety of mouse models that the hepatic